SCHEMBL24478962

SCHEMBL24478962

OC(c1c[nH]c2ncc(Br)cc12)C(F)(F)F

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DYRK1A Q13627 4/20 0.44
AURKA O14965 3/20 0.44
JAK2 O60674 3/20 0.44
MAP4K4 O95819 3/20 0.44
FGFR1 P11362 3/20 0.44
FLT1 P17948 3/20 0.44
KDR P35968 3/20 0.44
CLK2 P49760 3/20 0.44
CDK5 Q00535 3/20 0.44
MAP4K2 Q12851 3/20 0.44
AURKB Q96GD4 3/20 0.44
CLK4 Q9HAZ1 3/20 0.44
PRKD3 O94806 2/20 0.44
TAOK1 Q7L7X3 2/20 0.44
IGF1R P08069 2/20 0.44
JAK3 P52333 2/20 0.44
LIMK1 P53667 2/20 0.44
NTRK2 Q16620 2/20 0.44
PLK4 O00444 1/20 0.44
ROCK2 O75116 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15882584 0.76 AURKA (0.50) DYRK1AAURKAJAK2MAP4K4FGFR1
SCHEMBL13138395 0.74 DYRK1A (0.43) DYRK1AAURKAJAK2MAP4K4FGFR1
SCHEMBL859210 0.74 PRKD3 (0.49) DYRK1AAURKAJAK2MAP4K4FGFR1
SCHEMBL27678709 0.73 DYRK1A (0.44) DYRK1AAURKAJAK2MAP4K4FGFR1
SCHEMBL15882593 0.73 PLK4 (0.50) DYRK1AAURKAJAK2MAP4K4FGFR1
SCHEMBL19839227 0.73 GUSB (0.50) CSNK2A1IDO1
SCHEMBL24479128 0.72 PLK4 (0.37) DYRK1AAURKAJAK2MAP4K4FGFR1
SCHEMBL30768447 0.71 GUSB (0.55) DYRK1AAURKAJAK2MAP4K4FGFR1
SCHEMBL26696374 0.71 GUSB (0.55) DYRK1AAURKAJAK2MAP4K4FGFR1
SCHEMBL27775351 0.71 DYRK1A (0.43) DYRK1AAURKAJAK2MAP4K4FGFR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220169644-A1 BICYCLIC HPK1 INHIBITORS JANSSEN PHARMACEUTICA NV (BE) 2022-06-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220169644-A1 BICYCLIC HPK1 INHIBITORS PCK1, PGK1, PDXK DYRK1A 2022/4885AURKA 972/4885JAK2 3717/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.